DAIC

JUNE 13, 2024

It’s a celebration of the amazing innovation that has occurred in structural heart disease therapy over the last 20 years and I’m proud to be part of it. Improving patient care and outcomes is what drives my commitment to helping find new solutions in the field. standard-of-care for managing postpartum hemorrhage, the JADA System.

Cardiothoracic 104

Cardiothoracic Interventional Cardiology Bicuspid/Mitral Innovation 104

Stroke Journal

DECEMBER 15, 2023

Intracerebral hemorrhage is the most serious type of stroke, leading to high rates of severe disability and mortality. Hematoma expansion is an independent predictor of poor functional outcome and is a compelling target for intervention. Stroke, Ahead of Print.

Best Practices 75

Best Practices Hemorrhage Blood Pressure Innovation 75

Stroke Journal

MARCH 4, 2025

Subarachnoid hemorrhage is a critical neurological condition accounting for about 5% of all strokes, and survivors experience long-term cognitive deterioration and increased risk of dementia. Genetic predispositions have been associated with post-subarachnoid hemorrhage cognitive outcomes and emphasize a role for personalized care strategies.

Hemorrhage 40

Hemorrhage Genetic predisposition Genetic Markers Quality of Life 40

Stroke: Vascular and Interventional Neurology

JUNE 14, 2023

Primary outcomes included successful reperfusion rates and periprocedural ischemic and hemorrhagic events rates. Secondary outcomes included rates of ischemic events recurrence, other periprocedural events, and mortality. I2, 12%).

Hemorrhage 40

Hemorrhage Innovation Outcomes Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Understanding its mechanisms is vital for innovative treatments. and 24h post-stroke to analyze brain swelling, blood-brain barrier (BBB) leakage and hemorrhagic transformation (HT). Inhibiting C3 activation could be a potential therapeutic approach to improve hyperglycemic stroke outcome. Mice were sacrificed at 4.5h

Stroke 40

Stroke Strokes Innovation Hemorrhage 40

ADN Center of Excellence

OCTOBER 28, 2024

Its insidious nature often occurring without warning has profound implications for patient outcomes, underscoring the need for proactive prevention, rapid response, and advanced treatment strategies. Often called the "silent killer," stroke is a leading cause of death and disability worldwide.

Stroke 59

Stroke Strokes Education Innovation 59

Stroke Journal

JANUARY 30, 2025

proposed an innovative thromboembolic stroke model in mice where murine thrombin is injected into the M2 segment of the middle cerebral artery (MCA) to induce arterial thrombosis. It emerged as a sensitive but versatile and translationally tool for evaluating pharmacological efficacy and safety of innovative drugs.

Pharmacology 40

Pharmacology Stroke Strokes Thrombosis 40